Skip to main content
. 2019 Sep 17;12:7623–7636. doi: 10.2147/OTT.S208275

Table 1.

Enriched functions for the target genes of the downregulated miRNAs

 Terms Count P-value
Biological process (BP)
 GO:0007049~cell cycle 32 1.33E-07
 GO:0045893~positive regulation of transcription, DNA-templated 55 2.23E-07
 GO:0000122~negative regulation of transcription from RNA polymerase II promoter 69 3.35E-07
 GO:0000209~protein polyubiquitination 28 4.95E-07
 GO:0006468~protein phosphorylation 47 5.05E-06
 GO:0045944~positive regulation of transcription from RNA polymerase II promoter 82 5.62E-06
 GO:0051301~cell division 39 6.26E-06
 GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process 23 7.78E-06
 GO:0006351~transcription, DNA-templated 139 1.50E-05
 GO:0030879~mammary gland development 8 4.83E-05
Cellular component (CC)
 GO:0005829~cytosol 241 3.09E-12
 GO:0005737~cytoplasm 341 1.53E-11
 GO:0005654~nucleoplasm 204 1.61E-10
 GO:0005634~nucleus 337 9.46E-09
 GO:0005874~microtubule 33 4.18E-05
 GO:0035098~ESC/E (Z) complex 7 6.33E-05
 GO:0048471~perinuclear region of cytoplasm 53 6.82E-05
 GO:0043231~intracellular membrane-bounded organelle 48 1.32E-04
 GO:0030496~midbody 18 1.46E-04
 GO:0005794~Golgi apparatus 66 2.07E-04
Molecular function (MF)
 GO:0005515~protein binding 558 4.40E-18
 GO:0061630~ubiquitin protein ligase activity 33 8.23E-10
 GO:0019901~protein kinase binding 39 2.81E-05
 GO:0004842~ubiquitin-protein transferase activity 34 1.07E-04
 GO:0044822~poly (A) RNA binding 84 2.09E-04
 GO:0008270~zinc ion binding 86 2.56E-04
 GO:0016874~ligase activity 28 4.63E-04
 GO:0004672~protein kinase activity 34 5.33E-04
 GO:0008536~Ran GTPase binding 8 5.52E-04
 GO:0004674~protein serine/threonine kinase activity 35 5.92E-04
KEGG_PATHWAY
 hsa04722: Neurotrophin signaling pathway 22 1.53E-07
 hsa04151: PI3K-Akt signaling pathway 39 7.09E-07
 hsa04068: FoxO signaling pathway 22 1.04E-06
 hsa04510: Focal adhesion 28 1.18E-06
 hsa04914: Progesterone-mediated oocyte maturation 17 2.42E-06
 hsa04910: Insulin signaling pathway 21 6.52E-06
 hsa05211: Renal cell carcinoma 14 8.29E-06
 hsa04070: Phosphatidylinositol signaling system 17 1.20E-05